StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was $659.60M, up 119.2% from the year before. Over ten years it grew 5.9% a year on average. The highest annual figure on record is $845.02M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$659.60M+119.2%
FY2024Dec 31, 2024$300.98M-51.1%
FY2023Dec 31, 2023$615.27M-16.8%
FY2022Dec 31, 2022$739.86M-12.4%
FY2021Dec 31, 2021$845.02M+42.9%
FY2020Dec 31, 2020$591.45M+188.1%
FY2019Dec 31, 2019$205.32M-56.6%
FY2018Dec 31, 2018$473.02M+27.9%
FY2017Dec 31, 2017$369.87M+18.6%
FY2016Dec 31, 2016$311.88M-15.9%
FY2015Dec 31, 2015$370.97M+2.3%
FY2014Dec 31, 2014$362.48M+38.0%
FY2013Dec 31, 2013$262.69M-28.6%
FY2012Dec 31, 2012$367.71M+37.7%
FY2011Dec 31, 2011$266.97M-19.4%
FY2010Dec 31, 2010$331.32M+44.8%
FY2009Dec 31, 2009$228.78M+21.5%
FY2008Dec 31, 2008$188.28M–

More Qiagen figures

See a number that looks wrong?